Results 161 to 170 of about 278,879 (377)

Effects of oral cyclophosphamide and prednisolone therapy on the endothelial functions and clinical findings in patients with early diffuse systemic sclerosis

open access: green, 2003
Ş Apraş   +8 more
openalex   +2 more sources

Vaginal endometriosis following uterine transplantation in a patient with Mayer–Rokitansky–Küster–Hauser syndrome: A unique case report

open access: yes
International Journal of Gynecology &Obstetrics, EarlyView.
Jana Moravcova   +3 more
wiley   +1 more source

A Case of Pulmonary Hemosiderosis that was Dissolved by an Oral Prednisolone and the Milk Avoidance [PDF]

open access: bronze, 2012
Mi Suk Kim   +6 more
openalex   +1 more source

Assessing the hazard of death, cardiac tamponade, and pericardial constriction among HIV and tuberculosis pericarditis patients using the extended Cox‐hazard model: Intervention study

open access: yesHealth Science Reports
Background and Aims Tuberculous (TB) pericarditis (TBP), a TB of the heart, is linked to significant morbidity and mortality rates. Administering glucocorticoid therapy to individuals with TBP might enhance overall results and lower the likelihood of ...
Abdul‐Karim Iddrisu   +3 more
doaj   +1 more source

Protein-losing gastroenteropathy effectively trated by prednisolone.

open access: bronze, 2000
Hiroshi Murakami   +4 more
openalex   +2 more sources

Kaposiform hemangioendothelioma: Diagnosis and treatment

open access: yesPediatric Investigation, EarlyView.
Vascular endothelial growth factor‐C (VEGF‐C)/vascular endothelial growth factor receptor‐3 (VEGFR‐3) and angiopoietin‐2 (Ang‐2)/tyrosine kinase with immunoglobulin‐like and EGF‐like domain 2 (TIE2) signaling pathways play an important role in lymphangiogenesis.
Yi Tian   +5 more
wiley   +1 more source

Elevated serum aminotransferases in an infant with failure to thrive: A clinicopathological case report

open access: yes
JPGN Reports, EarlyView.
Jamie M. Klapp   +4 more
wiley   +1 more source

Post Hoc Subgroup Analysis of Clinical Outcomes in Patients With High‐Risk Metastatic Hormone‐Naïve Prostate Cancer: Results From a 3‐Year Interim Analysis of the J‐ROCK Study

open access: yesThe Prostate, EarlyView.
ABSTRACT Introduction In real‐world practice in Japan, standard treatment for metastatic hormone‐naïve prostate cancer (mHNPC) is androgen deprivation therapy (ADT), administered as monotherapy, combined androgen blockade (CAB), ADT plus androgen receptor pathway inhibitors (ARPIs), or ADT plus docetaxel.
Atsushi Mizokami   +14 more
wiley   +1 more source

Home - About - Disclaimer - Privacy